Stress-related disorders, pituitary adenylate cyclase-activating peptide (PACAP)ergic system, and sex differences.
Trauma-related disorders, such as posttraumatic stress disorder (PTSD) are remarkably common and debilitating, and are often characterized by dysregulated threat responses. Across numerous epidemiological studies, females have been found to have an approximately twofold increased risk for PTSD and other stress-related disorders. Understanding the biological mechanisms of this differential risk is of critical importance. Recent data suggest that the pituitary adenylate cyclase-activating polypeptide (PACAP) pathway is a critical regulator of the stress response across species. Moreover, increasing evidence suggests that this pathway is regulated by both stress and estrogen modulation and may provide an important window into understanding mechanisms of sex differences in the stress response. We have recently shown that PACAP and its receptor (PAC1R) are critical mediators of abnormal processes after psychological trauma. Notably, in heavily traumatized human subjects, there appears to be a robust sex-specific association of PACAP blood levels and PAC1R gene variants with fear physiology, PTSD diagnosis, and symptoms, specifically in females. The sex-specific association occurs within a single-nucleotide polymorphism (rs2267735) that resides in a putative estrogen response element involved in PAC1R gene regulation. Complementing these human data, the PAC1R messenger RNA is induced with fear conditioning or estrogen replacement in rodent models. These data suggest that perturbations in the PACAP-PAC1R pathway are regulated by estrogen and are involved in abnormal fear responses underlying PTSD.
Department of Psychiatry, McClean Hospital, Harvard Medical School, Belmont, Massachusetts, USA.
Teniel S
TS
Ramikie
Department of Psychiatry, McClean Hospital, Harvard Medical School, Belmont, Massachusetts, USA.
Kerry J
KJ
Ressler
D000223:Adaptation, Psychological / Q000502:physiology; D000818:Animals; D015415:Biomarkers / Q000097:blood; D004967:Estrogens / Q000502:physiology; D005239:Fear / Q000502:physiology; D005260:Female; D059647:Gene-Environment Interaction; D006801:Humans; D008297:Male; D008568:Memory / Q000502:physiology; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide / Q000097:blood / Q000235:genetics / Q000502:physiology*; D011110:Polymorphism, Genetic; D051237:Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I / Q000235:genetics / Q000502:physiology*; D012307:Risk Factors; D012727:Sex Characteristics; D012737:Sex Factors; D013313:Stress Disorders, Post-Traumatic / Q000097:blood / Q000235:genetics / Q000503:physiopathology*; D013312:Stress, Physiological / Q000235:genetics / Q000502:physiology; D013315:Stress, Psychological / Q000235:genetics / Q000503:physiopathology*
C495401:ADCYAP1 protein, human; D015415:Biomarkers; D004967:Estrogens; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D051237:Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I
ADCYAP1; ADCYAP1R1; PACAP; PTSD; amygdala; anxiety; estrogen; fear; fear conditioning; genetic; sex difference; threat